0.024% of GDP: India Proposes to Sextuple Health Research Spending by 2047
The draft policy's more radical move is not the money but the metric — researchers judged on clinical guidelines changed, not papers published
What happened
Science policy answers usually turn on money, and this draft supplies a striking number. But the analytically interesting proposal is the evaluation framework, because it attacks a failure that extra funding alone would amplify — research that is published and never applied. Learn the spending trajectory for the facts, and the ICMR-IRIS shift for the argument, because measuring impact rather than output is what determines whether the additional money buys health outcomes or citations.
Health Research Spending as a Share of GDP
India's Proposed Trajectory vs the Benchmark
To (ICMR-IRIS, 2025): clinical guidelines changed · programmes influenced · policy shaped · indigenous technologies · measurable health outcomes
Source: Draft National Health Research Policy, 2026, Department of Health Research; ICMR
The Draft National Health Research Policy, 2026 was released by the Department of Health Research (DHR) — the department within the Ministry of Health and Family Welfare that houses the Indian Council of Medical Research — and is open for public comment until 27 July 2026.
●It is described as the first unified national framework spanning all areas of health research.
●Spending: India currently devotes about 0.024 per cent of GDP to health research against roughly 0.27 per cent in high-income countries; the draft targets 0.072 per cent by 2037 and 0.15 per cent by 2047, a roughly six-fold increase in government funding.
●Priority areas: tuberculosis, antimicrobial resistance, vector-borne diseases, cancer, non-communicable diseases, mental health, anaemia, child malnutrition, women's health, maternal and neonatal mortality, primary healthcare and emergency care.
●Governance: a National Health Research Stewardship Committee for strategic coordination, the DHR as nodal implementing agency, and the ICMR as scientific and technical lead.
●Evaluation: expanded use of the ICMR Impact of Research and Innovation Scale (ICMR-IRIS), introduced in 2025, which assesses contribution to clinical guidelines, public health programmes, policymaking, indigenous technologies, innovation, capacity building and measurable improvements in health outcomes.
Even at the 2047 target of 0.15 per cent, India would remain below what high-income countries spend today — the trajectory closes part of the gap, not the gap.
◎ In Simple Words
India spends very little on medical research — about two and a half paise out of every hundred rupees of national income, compared with roughly twenty-seven paise in rich countries. A new draft policy proposes multiplying that by about six times over the next twenty years. It also lists the diseases India should focus on, such as tuberculosis, cancer and childhood malnutrition. The most interesting change is how scientists will be judged: not by how many research papers they publish, but by whether their work actually changed how doctors treat patients or how health programmes are run.
Factual Pointers
Practice · 2 questions
With reference to the Draft National Health Research Policy, 2026, consider the following statements:
1. It proposes raising health research spending to 0.15 per cent of GDP by 2047.
2. The Indian Council of Medical Research is proposed as the scientific and technical lead.
3. It proposes evaluating research primarily by the number of publications and grants awarded.
Which of the statements given above are correct?
The Department of Health Research (DHR), which released the draft policy, functions under which Union Ministry?
Mains Practice Questions
"A six-fold increase in research funding evaluated on publication counts would buy six times the citations, not better health." Critically examine the Draft National Health Research Policy, 2026 in this light. (250 words, GS2)
For a country with India's disease burden, domestic health research capacity is not a matter of prestige but a necessity. Discuss. (250 words, GS3)
Impact-based assessment of scientific research carries risks for basic science. Examine. (150 words, GS3)
Frequently Asked
· People also askHow much does India spend on health research?
About 0.024 per cent of GDP — roughly a tenth of the 0.27 per cent average in high-income countries. The Draft National Health Research Policy, 2026 proposes raising this to 0.072 per cent by 2037 and 0.15 per cent by 2047, a roughly six-fold increase.
Prelims · GS2Even at the 2047 target India would remain below what high-income countries spend today, so the trajectory arrests relative decline rather than achieving parity.
SOURCE Department of Health Research
What is ICMR-IRIS?
The ICMR Impact of Research and Innovation Scale, introduced in 2025, assesses research by its real-world impact — whether it contributed to clinical guidelines, public health programmes, policymaking, indigenous technologies, innovation, capacity building and measurable improvements in health outcomes — rather than counting publications.
GS3 · S&TThe draft policy proposes expanding its use. This is arguably its most consequential reform, since additional funding evaluated on publication counts would increase output without necessarily improving health.
SOURCE Indian Council of Medical Research
Which research areas does the draft prioritise?
Tuberculosis, antimicrobial resistance, vector-borne diseases, cancer, non-communicable diseases, mental health, anaemia, child malnutrition, women's health, maternal and neonatal mortality, primary healthcare and emergency care.
GS2 · HealthThe list spans both India's unfinished communicable-disease burden and its epidemiological transition to non-communicable disease — India must research both simultaneously, unlike countries that completed one phase before entering the next.
SOURCE Draft National Health Research Policy, 2026
Who will govern health research under the draft?
A National Health Research Stewardship Committee would provide strategic coordination, the Department of Health Research would act as nodal implementing agency, and the Indian Council of Medical Research would serve as scientific and technical lead.
GS2 · GovernanceThe structure responds to genuine fragmentation across DHR, the Department of Biotechnology, the Department of Science and Technology, CSIR and state institutions — though such bodies succeed or fail on whether they control allocation or merely advise.
SOURCE Draft National Health Research Policy, 2026
Why does India need its own health research capacity?
Because research priorities elsewhere follow other countries' disease burden and markets. Conditions concentrated in India — tuberculosis, locally specific antimicrobial resistance patterns, anaemia, vector-borne diseases — attract little external effort, so domestic capacity is the only realistic route to evidence about Indian patients.
GS3 · S&TAntimicrobial resistance is the sharpest case: resistance patterns are population- and geography-specific, so India cannot import evidence about its own pathogen ecology.
SOURCE Draft National Health Research Policy, 2026
What are the risks of impact-based assessment?
Impact is slow, diffuse and collectively produced — a guideline change may follow a decade of work by many groups, so attributing it to an individual is contestable. Poorly designed, such metrics can penalise basic science whose value is real but indirect, and favour applied work with visible short-run outputs.
GS3 · EthicsThe design question is whether the scale accommodates long-horizon and foundational research rather than crowding it out, and whether it counts improvements among the poorest rather than rewarding research on patients who can pay.
SOURCE Draft National Health Research Policy, 2026